Research Article
A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer
Table 3
Descriptive characteristics of patients with no csPCa and csPCa.
| | Variables | No csPCa () | csPCa () | value |
| | Age (y) | 66 (60, 72) | 72 (66, 77) | <0.001 | | BMI (kg/m2) | 23.53 (21.67, 25.49) | 23.88 (21.80, 25.82) | 0.111 | | AISI | 195.65 (127.02, 292.69) | 277.45 (187.15, 423.85) | <0.001 | | SII | 485.47 (345.15, 703.70) | 534.74 (384.76, 744.21) | 0.017 | | NLR | 2.38 (1.84, 3.24) | 2.53 (1.98, 3.34) | 0.044 | | PLR | 131.88 (104.39, 166.03) | 132.56 (107.47, 170.82) | 0.603 | | tPSA (ng/ml) | 8.64 (5.44, 12.57) | 20.79 (10.21, 54.76) | <0.001 | | fPSA (ng/ml) | 1.18 (0.75, 2.05) | 2.25 (1.09, 6.30) | <0.001 | | f/tPSA | 0.15 (0.10, 0.22) | 0.11 (0.07, 0.15) | <0.001 | | PV (ml) | 46.30 (33.02, 66.06) | 35.83 (26.18, 53.86) | <0.001 | | HBP | | | 0.612 | | No | 262 (58.6%) | 231 (56.9%) | | | Yes | 185 (41.4%) | 175 (43.1%) | | | DM | | | 0.492 | | No | 408 (91.3%) | 365 (89.9%) | | | Yes | 39 (8.7%) | 41 (10.1%) | | | PIRADS score | | | <0.001 | | 1 | 31 (6.9%) | 9 (2.2%) | | | 2 | 141 (31.5%) | 16 (3.9%) | | | 3 | 142 (31.8%) | 47 (11.6%) | | | 4 | 112 (25.1%) | 148 (36.5%) | | | 5 | 21 (4.7%) | 186 (45.8%) | |
|
|
